127 related articles for article (PubMed ID: 37338116)
21. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
Myong NH
J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
23. [TTF-1 expression and its diagnostic application in lung carcinomas].
Lin DM; Zou SM; Lü N; Wen P; Liu XY; He ZG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):615-7. PubMed ID: 15634524
[TBL] [Abstract][Full Text] [Related]
24. Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF; Wang XC; Chen Y; Wang JY; Liu X; Li X; Li CW; Xie YC; Luo Y; Shang XQ; Guo J
Oncol Rep; 2012 Nov; 28(5):1544-50. PubMed ID: 22940844
[TBL] [Abstract][Full Text] [Related]
25. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
[TBL] [Abstract][Full Text] [Related]
26. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
27. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.
Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A
Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709
[TBL] [Abstract][Full Text] [Related]
28. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.
Fujita J; Ohtsuki Y; Bandoh S; Ueda Y; Kubo A; Tojo Y; Yamaji Y; Ishida T
Lung Cancer; 2003 Jan; 39(1):31-6. PubMed ID: 12499091
[TBL] [Abstract][Full Text] [Related]
29. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
[TBL] [Abstract][Full Text] [Related]
30. Slug is associated with poor survival in squamous cell carcinoma of the lung.
Merikallio H; T TT; Pääkkö P; Mäkitaro R; Kaarteenaho R; Lehtonen S; Salo S; Salo T; Harju T; Soini Y
Int J Clin Exp Pathol; 2014; 7(9):5846-54. PubMed ID: 25337226
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J
Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941
[TBL] [Abstract][Full Text] [Related]
34. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
[TBL] [Abstract][Full Text] [Related]
35. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
36. [Quantitative study of thyroid transcription factor-1 protein expression in lung carcinoma cell nucleus by tissue microarray].
Bai XY; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1423-6. PubMed ID: 17062341
[TBL] [Abstract][Full Text] [Related]
37. Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma.
Miyamae Y; Shimizu K; Hirato J; Araki T; Tanaka K; Ogawa H; Kakegawa S; Sugano M; Nakano T; Mitani Y; Kaira K; Takeyoshi I
Oncol Rep; 2011 Apr; 25(4):921-8. PubMed ID: 21318227
[TBL] [Abstract][Full Text] [Related]
38. Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.
Molinier O; Goupil F; Debieuvre D; Auliac JB; Jeandeau S; Lacroix S; Martin F; Grivaux M
Respir Med Res; 2020 Mar; 77():46-54. PubMed ID: 32036284
[TBL] [Abstract][Full Text] [Related]
39. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
[TBL] [Abstract][Full Text] [Related]
40. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]